Partial Netrin-1 Deficiency Aggravates Acute Kidney Injury by Grenz, Almut et al.
Partial Netrin-1 Deficiency Aggravates Acute Kidney
Injury
Almut Grenz
1*, Julee H. Dalton





2, Carol M. Aherne
1, Kelley S. Brodsky
1, Jae-Hwan Kim




1Mucosal Inflammation Program, Department of Anesthesiology, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado, United States of America,
2Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado, United States of America,
3Department of Anesthesiology, Korea University College of Medicine, Seoul, Republic of Korea
Abstract
The netrin family of secreted proteins provides migrational cues in the developing central nervous system. Recently, netrins
have also been shown to regulate diverse processes beyond their functions in the brain, incluing the ochrestration of
inflammatory events. Particularly netrin-1 has been implicated in dampening hypoxia-induced inflammation. Here, we
hypothesized an anti-inflammatory role of endogenous netrin-1 in acute kidney injury (AKI). As homozygous deletion of
netrin-1 is lethal, we studied mice with partial netrin-1 deletion (Ntn-1
+/2 mice) as a genetic model. In fact, Ntn-1
+/2 mice
showed attenuated Ntn-1 levels at baseline and following ischemic AKI. Functional studies of AKI induced by 30 min of renal
ischemia and reperfusion revealed enhanced kidney dysfunction in Ntn-1
+/2 mice as assessed by measurements of
glomerular filtration, urine flow rate, urine electrolytes, serum creatinine and creatinine clearance. Consistent with these
findings, histological studies indicated a more severe degree kidney injury. Similarly, elevations of renal and systemic
inflammatory markers were enhanced in mice with partial netrin-1 deficiency. Finally, treatment of Ntn-1
+/2 mice with
exogenous netrin-1 restored a normal phenotype during AKI. Taking together, these studies implicate endogenous netrin-1
in attenuating renal inflammation during AKI.
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Introduction
Acute kidney injury (AKI) is defined a decrease in the
glomerular filtration rate (GFR), occurring over a period of
minutes to days. AKI is frequently caused by renal ischemia, and
represents an important cause of morbidity and mortality of
hospitalized patients [1,2,3]. A recent study revealed that only a
mild increase in the serum creatinine level (0.3 mg/dl) is
associated with a 70% greater risk of death than in patients
without any increase [2,3]. Along these lines, surgical procedures
requiring cross-clamping of the aorta and renal vessels are
associated with a rate of AKI of up to 30% [4]. Similarly, acute
renal failure after cardiac surgery occurs in up to 10% of patients
under normal circumstances and is associated with dramatic
increases in mortality [5]. Moreover, patients with sepsis
frequently go on to develop AKI and the combination of
moderate sepsis and AKI is associated with a 70% rate of
mortality. Therapeutic approaches are very limited and the
majority of interventional trials in AKI have failed in humans
[6]. Therefore, additional therapeutic modalities to prevent or
treat AKI presently represent an area of intense investigation [7].
Named after the Sanskrit word netr, which means ‘one who
guides’, the netrin family of secreted proteins provides migrational
cues in the developing central nervous system. More recently,
netrins have been shown to regulate diverse processes (such as cell
adhesion, motility, proliferation, differentiation and, ultimately, cell
survival) in a number of non-neuronal tissues [8]. The ability of the
guidance molecule netrin-1 (Ntn-1) to repulse or abolish attraction
of neuronal cells makes it an attractive candidate for the regulation
of inflammatory cell migration. In fact, previous studies have shown
that Ntn-1 is involved in the orchestration of inflammatory
responses in vitro or in vivo [9,10]. Particularly, netrin-1 has been
implicated in regulating inflammatory events during conditions of
tissue hypoxia [9]. Given that mucosal surfaces are particularly
prone to hypoxia-elicited inflammation, a recent study sought to
determinethefunctionofnetrin-1inhypoxia-inducedinflammation
[9]. The authors observed hypoxia-inducible factor 1alpha (HIF-
1a)-dependent induction of expression of the gene encoding Ntn1 in
hypoxic epithelia. Neutrophil transepithelial migration studies
showed that by engaging A2B adenosine receptor (A2BAR) on
neutrophils, netrin-1attenuatedneutrophiltransmigration.Another
study demonstrated that endothelial netrin-1 interacts with
inflammatory cells and is capable of attenuating inflammation by
potent inhibition of myeloid cell migration [10]. Taken together,
these studies indicate that netrin-1 attenuates organ injury by
hypoxia or inflammation [9].
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e14812Recent studies in the kidney showed that exogenous netrin-1
treatment in mice or renal ischemia in mice overexpressing renal
netrin-1 attenuated kidney injury following ischemia [11,12]. The
same authors showed that UNC5B receptors on leucocytes
attenuate kidney injury due to ischemia [13]. Furthermore they
showed that urinary netrin-1 excretion is increased in patients
following acute renal failure compared to urine from healthy
controls suggesting netrin-1 as an early biomarker for acute renal
failure [14]. However, studies in gene-targeted mice for netrin-1
have not been performed.
Due to the fact that AKI is characterized by an acute
inflammatory event in the context of tissue hypoxia, we
hypothesized a role of endogenous netrin-1 in dampening
ischemia-driven inflammation and kidney dysfunction during
AKI. We were particularly interested in identifying the role of
endogenous netrin-1 in this response – as the adult kidney was
previously shown to be the single organ with the highest expression
of netrin-1 (even higher than the brain) [10]. Based on previous
studies showing that netrin-1 is induced during conditions of
limited oxygen availability (hypoxia), and dampens hypoxia-
induced inflammation [9], we hypothesized a role for endogenous
netrin-1 in dampening renal failure after AKI. In fact, studies of in
gene-targeted mice for netrin-1 confirmed our hypothesis and
indicate a protective role of endogenous netrin-1 in AKI.
Material and Methods
In vivo model of AKI
The animal protocol was approved by the Institutional Animal
Care and Use Committee of the University of Colorado Denver,
and is in accordance with the National Institutes of Health
guidelines for use of live animals. Previously described Ntn-1
+/2
mice or Ntn-1
+/+ mice littermate controls matched in age, gender,
and weight were used [15].
Mice were anaesthetized using 50 mg/kg i.p. pentobarbital and
underwent right nephrectomy followed by left renal artery
ischemia for 30 minutes by using a hanging weight system, as
previously described [16,17,18,19]. Plasma creatinine and urine
Figure 1. Renal netrin-1 expression in wild-type mice (Ntn1
+/+) or mice with partial netrin-1 deficiency (Ntn1
+/2). (A) Real-time RT-PCR
analysis of the expression of Ntn1 mRNA in the kidneys of Ntn1
+/+ and Ntn1
+/2 mice, presented relative to b-actin. Data are representative of four
mice in each group (mean 6 SD). (B,C) Expression of netrin-1 protein in Ntn1
+/+ or Ntn1
+/2 mice. (D,E) Expression of netrin-1 protein in kidneys of
Ntn1
+/+ or Ntn1
+/2 mice following 30 minutes of ischemia and 2 hours reperfusion (+I) compared to control kidneys without ischemia (2I). Each blot
was re-probed for b-actin to control for loading. One representative of three blots is displayed.
doi:10.1371/journal.pone.0014812.g001
Netrin-1 in AKI
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ischemia by the hospital laboratory and kidneys were harvested
and stored at 280uC until further analysis. Inulin clearance was
measured 60 minutes following renal ischemia as described
previously [17]. Briefly, the right jugular vein was cannulated for
continuous infusion. Next, 0.75% FITC-inulin was added to the
infusion for determination of glomerular filtration rate (GFR).
Blood samples were taken via retroorbital puncture. A catheter
was placed in the urinary bladder for timed urine collection. Three
urine collection periods were performed with blood collection in
the middle of the period. FITC-inulin concentrations in plasma
and urine samples were measured.
Cell culture and hypoxia exposure
Human renal epithelial cells (HK-2) were exposed to normo-
baric hypoxia (1% O2, 99%N2) in a hypoxic chamber (hypoxic
glove box, COY Laboratory Products INC. Michigan, USA) over
indicated time periods.
Transcriptional Studies
We used real-time RT-PCR (iCycler; Bio-Rad Laboratories
Inc.) to examine Ntn-1, IL-6, TNF-a and IL-10 expression in renal
tissue as previously described [9,13]. Primer sets (sense sequence,
antisense sequence, and transcript size, respectively) for the
following genes were: netrin-1 (59- CTCACAGCAATGTCAA-
CAGC -39,5 9- GCAGGAAGCAGTCACAGAAT -39, 191 bp);
IL6 (59 - CGG AGA GGA GAC TTC ACA GA -39,5 9 - CCA
GTT TGG TAG CAT CCA TC -39, 218 bp); TNF-a (59-
CCCACTCTGACCCCTTTACT -39,5 9- TTTGAGTCCTT-
GATGGTGGT -39, 201 bp); IL-10 (59-CCCAAGTAACCCT-
TAAAGTCCTTGC, 59-ATGCTGCCTGCTCTTACTGACT-
G-39, 200 bp). Murine ß-actin mRNA (59- CTAGGCACCA-
GGGTGTGAT -39,5 9- TGCCAGATCTTCTTCATGTC -39)
was amplified in identical reactions to control for the amount of
starting template.
Renal histology
Kidneys were excised and harvested 24 hours following
30 minutes of ischemia. Paraffin-embedded sections (3 mm) were
stained with hematoxylin and eosin or rat anti-mouse neutrophil
MCA771G antibody (Abd Serotec, NC, USA) to assess neutrophil
accumulation in the kidneys [17].
Human and mouse protein analysis
Renal tissues and renal epithelial cells (HK-2 cells) were blotted
using polyclonal rabbit anti-netrin-1 (Calbiochem Laboratories)
and polyclonal goat anti-netrin-1 (Santa Cruz), respectively [9].
Immunohistochemistry
Immunohistochemistry for NTN-1 on 3-mm-thick kidney
sections was performed using formalin-fixed, paraffin-embedded
tissue and sections that were stained with polyclonal rabbit anti-
mouse netrin-1 (Calbiochem Laboratories) [9].
Netrin-1 ELISA
Netrin-1 in renal tissue and urine was measured using a
commercially available ELISA kit (Hoelzel Diagnostika, Germany).
Statistic analysis
Data are presented as mean 6 SD from four to six animals per
condition. We performed statistical analysis using the Student t test
(two sided, ,0.05). Renal injury scores were analyzed with the
Kruskal-Wallis rank test and are given as median 6 range. A value
of p,0.05 was considered statistically significant.
Figure 2. Immunohistochemical localization of renal netrin-1 and netrin-1 tissue content and urine concentration following
ischemia in vivo. Immunohistolochemical staining for netrin-1 in kidneys of Ntn1
+/2 mice or their respective age-, weight-, and gender-matched
littermate controls (Ntn1
+/+) following 30 minutes ischemia and 2 hours reperfusion. (A) Netrin-1 protein is mainly expressed in tubule cells of Ntn1
+/+
mice under basal conditions without ischemia (2I) and (B) is increased following ischemia (+I). (C,D) This increase of netrin-1 expression following
ischemia is attenuated in Ntn1
+/2 mice. Arrows indicate tubules with netrin-1 expression. (magnification 4006). (E) Renal and (F) urine netrin-1
content were assessed by ELISA (mean 6 SD; n=6–8).
doi:10.1371/journal.pone.0014812.g002
Figure 3. In vitro expression of netrin-1 in HK-2 cells. (A) Expression of netrin-1 in human renal epithelial cells (HK-2 cells) following exposure to
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+/2) exposed to ischemic AKI. Previously characterized Ntn1
+/2
mice or their respective age-, weight-, and gender-matched littermate controls (Ntn1
+/+) underwent right nephrectomy and were exposed
subsequenctly to AKI induced by 30 minutes of left renal artery ischemia. (A) Glomerular filtration rates (as measured by FITC-inulin clearance) were
obtained after 1 hour of reperfusion. (B) Urinary flow rate, (C) urinary potassium excretion, (D) serum creatinine and (E) creatinine clearance were
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Renal netrin-1 expression in Ntn-1
+/2 mice
To study the role of endogenous netrin-1 in AKI, we utilized
previously described mice with genetic deletion of netrin-1 [9,15].
Homozygote mice gene-targeted for netrin-1 are not viable, and
die shortly after birth [15]. Therefore, we examined mice with
partial netrin-deficiency (Ntn-1
+/2 mice) [9]. Initial characteriza-
tion of renal netrin-1 expression in Ntn-1
+/2 mice revealed
significant reduction of netrin-1 transcript and protein levels at
baseline (Figure 1A–C). As next step, we induced ischemic AKI
in wild-type mice (30 min of renal ischemia followed by 2 h of
reperfusion, Figure 1 D, E) and observed robust increases of renal
netrin-1 levels. In contrast, renal netrin-1 levels in Ntn-1
+/2 mice
exposed to AKI remained approximately at wild-type baseline
levels. Immunohistochemistry for renal netrin-1 indicated
dominant netrin-1 expression in proximal tubular cells, in
conjunction with increased netrin-1 levels following renal
ischemia. In contrast, renal netrin-1 staining at baseline or
following renal ischemia was attenuated in Ntn-1
+/2 mice. To
further define netrin-1 expression we measured netrin-1 in renal
tissue, urine and serum via ELISA. Interestingly we could show a
tremendous increase of netrin-1 in renal tissue and urine
following ischemia in wild-type control mice compared to Ntn-
1
+/2 mice, whereas serum concentrations were not detectable
assuming that netrin-1 expression occurs mainly in renal
epithelial cells (Figure 2E, F). Similarly, renal epithelial cells
(HK-2 cells) showed robust expression of netrin-1 in conjunction
with netrin-1 induction following exposure to ambient hypoxia
(1% oxygen over 0–24 h, Figure 3A and B). Taken together,
these studies indicate robust netrin-1 expression predominantly in
renal epithelia, and suggest that mice with partial netrin-1
deficiency can be used as a model to study endogenous netrin-1
during ischemia-induced AKI.
AKI is aggravated in Ntn-1
+/2 mice
After having characterized renal netrin-1 expression at baseline
or following AKI, we next pursued functional studies of AKI in
Ntn-1
+/2 mice. For this purpose, we utilized a previously described
model of ischemia induced AKI where isolated renal artery
occlusion is achieved via a hanging weight system, thereby
minimizing surgical trauma [16,17,18,19]. In short, we performed
a unilateral nephrectomy, followed by selective left renal artery
occlusion via a hanging weight-system in the remaining kidney to
induce AKI [16]. Following 30 min of renal ischemia and 1 hour
of reperfusion, we measured glomerular filtration rate by infusion
of FITC-labeled inulin via a jugular vein infusion catheter. These
studies revealed a significantly enhanced decrease in renal GFR
following AKI induction in Ntn-1
+/2 mice as compared to
littermate controls matched in age, gender and weight
(Figure 4A). Similarly, measurements of urinary flow rate,
potassium excretion, serum creatinine and creatinine clearance
measured 24 hours following renal ischemia, indicate a more
severe degree of AKI in mice with partial netrin-1 deficiency
(Figure 4B–E). Moreover, studies of renal histology demonstrate
more severe acute tubular necrosis—obvious from the loss of
tubular cell nuclei in the cortex and outer medulla with destruction
of the proximal tubular brush border. In addition, hyaline cast
formation, intraluminal necrotic cellular debris, and casts
containing brush border blebs were more predominant in Ntn-
1
+/2 mice exposed to renal ischemia (Figure 5A–D). This was
confirmed utilizing a histologic score for the severity of AKI
(Figure 5E). Together, these studies indicate that ischemia-induced
AKI is more severe in Ntn-1
+/2 mice.
AKI induced renal inflammation is enhanced following
partial Ntn-1
+/2 deficiency
Based on previous studies indicating that netrin-1 signaling
dampens acute inflammatory events induced by hypoxia [9], we
Figure 5. Histological tissue insure induced by AKI in mice with partial netrin-1 deficiency (Ntn1
+/2) or control mice (Ntn1
+/+). Renal
histology in Ntn1
+/2 mice exposed to renal ischemia or age-, weight-, and gender-matched littermate controls (Ntn1
+/+) were subjected to 30 minutes
of left renal artery ischemia. Renal histology was obtained after 24 hours of reperfusion. (A–D) Representative H&E staining (4006). Arrow marks
destructed tubules. (E) Quantification of histological tissue damage assessed by Jablonski index.
doi:10.1371/journal.pone.0014812.g005
Netrin-1 in AKI
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renal inflammation. Here, histological staining, or measurements of
renal myeloperoxidase indicate that neutrophil accumulation
following AKI is enhanced in Ntn-1
+/2 mice (Figure 6A–E).
Moreover, AKI-induced elevations of renal inflammatory markers
including TNF-a and IL-6 were enhanced whereas the anti-
inflammatory cytokine IL -10 was reduced in mice with partial
netrin-1 deficiency (Figure 6F–H). Together, these studies suggest
that endogenous netrin-1 signaling represents an endogenous
feedback loop to dampen AKI-induced inflammation of the kidneys.
Reconstitution of Ntn-1
+/2 mice during AKI
As proof of principle for the assertion that netrin-1 plays an
important role in the regulation of renal injury and kidney
inflammation during AKI, we reconstituted Ntn-1
+/2 mice with
exogenous netrin-1 (5 mg/mouse I.V. 30 min prior to induction of
AKI) [9]. We have chosen this netrin-1 dose based on previous
studies testing different netrin-1 doses (0.5, 1, 5, 10 mg/mouse I.V.)
showing the strongest renal protection from ischemia injury with
5 mg/mouse. In fact, these studies revealed that reconstitution with
exogenous netrin-1 restored a wild-type phenotype for AKI-
induced changes of GFR or renal inflammation following AKI in
Ntn-1
+/2 mice (Figure 7A and B). Taken together, these studies
provide strong evidence that netrin-1 signaling is a critical control
point for kidney inflammation and tissue injury following AKI.
Discussion
Tissue hypoxia during AKI results in severe kidney inflamma-
tion, including inflammatory cell accumulation, cytokine release,
and inflammation-associated organ dysfunction. Based on recent
studies suggesting a role of the neuronal guidance molecule netrin-
1 in dampening hypoxia-elicited inflammation [9], we examined
the role of netrin-1 in AKI. Utilizing mice with partial netrin-1
deficiency (Ntn-1
+/2 mice) we found that these mice are more
prone to AKI-induced kidney dysfunction and renal inflammation.
Moreover, reconstitution of Ntn-1
+/2 mice with exogenous netrin-
1 retreatment resuscitated their phenotype. Taken together, these
studies provide the first genetic in vivo evidence for a critical role of
endogenous netrin-1 in attenuating AKI-driven renal dysfunction
and inflammation.
At present, the signaling pathways involving renal protection
through netrin-1 remain unclear. Previous studies have indicated
that endogenous netrin-1 is released into the urine, and can serve
as an early biomarker of AKI [14,20]. Other studies suggest that
netrin-1 signaling via activation of the UNC5B receptor protects
the kidneys from ischemia [11,21]. Moreover, a very elegant study
utilizing a genetic model of netrin-1 overexpression demonstrates
that netrin-1 signaling protects the kidneys from ischemia
reperfusion injury by suppressing tubular epithelial apoptosis
[12]. Finally, another study suggests that anti-inflammatory
signaling events of netrin-1 involve the A2B adenosine receptor
(A2BAR), particularly during conditions of hypoxia-elicited
inflammation [9]. While the mechanisms of how netrin-1 interacts
with the A2BAR remain unclear, this study demonstrates that
netrin-1 signaling events enhance adenosine-dependent tissue
protection from hypoxia [9,17,22,23,24,25]. This assumption
would be consistent with other studies on the role of the A2BAR
in myocardial ischemia [23,25], vascular leakage [26,27],
intestinal inflammation [24,28,29], or acute lung injury [22,30],
where hypoxia-elicited induction of the A2BAR [31] attenuates
organ inflammation and dysfunction. In fact, hypoxia has been
shown to drive a coordinated adenosine response of different
tissues [32,33,34,35], including increased adenosine production
[36,37,38,39,40,41,42,43,44], induction of the A2BAR [45],
attenuated adenosine uptake [46,47,48] and metabolism [49],
thereby enhancing anti-inflammatory and protective tissue
responses during acute hypoxia [50,51,52]. In fact, extracellular
adenosine signaling has been strongly implicated as a therapeutic
in different models of kidney injury, including AKI [17,18,
19,23,53,54,55].
Figure 6. Renal inflammatory changes in Ntn1
+/2 mice following ischemia. Ntn1
+/2 mice and their respective age-, weight-, and gender-
matched littermate controls (Ntn1
+/+) were subjected to 30 minutes of left renal artery ischemia. (A–D) Neutrophil staining. Arrows indicate
neutrophils (magnification 4006). (E) Quantification of neutrophil tissue accumulation by measurement of myeloperoxidase (MPO). (F) TNF-a and
(G) interleukin-6 (IL-6) and (H) interleukin-10 (IL-10) were assessed by real-time RT-PCR from renal tissues. Data were calculated relative to ß-actin and
are expressed as fold change compared to sham-operated animals without ischemia (2I). Data are representative of four to six independent
experiments for each experimental condition (mean 6 SD).
doi:10.1371/journal.pone.0014812.g006
Figure 7. Reconstitution of Ntn1
+/2 mice with exogenous
netrin-1. Renal function and inflammation in mice with partial
deficiency for netrin-1 (Ntn1
+/2) treated with exogenous netrin (5 mg/
mouse I.V.) or vehicle prior to 30 minutes of renal ischemia.
(A) Glomerular filtration rate (as measured by FITC-inulin clearance)
was measured after 1 hour of reperfusion. (B) Quantification of
neutrophil tissue accumulation by measurement of myeloperoxidase
(MPO) (mean 6 SD; n=6–8).
doi:10.1371/journal.pone.0014812.g007
Netrin-1 in AKI
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as an endogenous anti-inflammatory during AKI. Future studies
will have to determine the exact contribution of different tissues,
e.g. by utilizing tissue-specific approaches of netrin-1 deletion, or
its receptor in the kidneys. Moreover, a more mechanistic
understanding of netrin-1 signaling events would set the stage
for targeting netrin-1 in the treatment of patients suffering from
AKI, e.g. by designing specific netrin-1 mimetic peptides. Finally,
future challenges require to address the consequences of acute
versus a more chronic activation of netrin-1-dependent signaling
pathways. For instance, previous studies have implicated chronic
activation of adenosine signaling pathways in promoting a chronic
form of disease and tissue fibrosis [56,57,58,59], whereas
adenosine signaling events in an acute setting dampen inflamma-
tory responses and contribute to the resolution of injury
[24,29,30,35,39,46,51,60,61].
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